Request to Join
has invited you to join this group
How would you use digital tools to prevent a health crisis or better manage a chronic condition? Concepts leveraging patient or population health data, patient monitoring and/or predictive analytics within the following disease areas are most attractive: cardiovascular; digestive; cancer; neurological / chronic pain; respiratory; and/or urology and pelvic health.
How would you use digital tools to prevent a health crisis or better manage a chronic condition? Concepts leveraging patient or population health data, patient monitoring and/or predictive...Read More
Bryan Clark is an R&D Fellow at Boston Scientific with over 13 years of experience innovating and commercializing technologies in the healthcare industry. His current focus is on identifying and developing new solutions to solve unmet clinical needs and fostering growth in white space areas, developing partnerships with external institutions and connecting across disciplines to drive innovation in healthcare. He has led numerous projects and partnerships across multiple technology and disease state areas including bioelectric medicine, digital health, cardiovascular disease, pulmonary disease, urological disorders, and chronic pain. He holds a Bachelor of Science in Composite Materials Engineering from Winona State University and an MBA from the Carlson School of Management at the University of Minnesota.
David is responsible for evolving Boston Scientific's Digital Health strategy, enabling capability building and leading the Big Data, Internet of Things (IoT), Analytics and Mobility teams.
Previously, As VP of Health IT Integration and Innovation at BD, David was responsible for the integration and development of customer facing Health IT capabilities and the identification, synthesis, development and execution of BD's solution expansion across Digital Health. David led corporate commercial Health IT development, product cybersecurity, public cloud, IoT operations and enterprise commercial alignment.
As Vice President of Corporate Strategic Innovation for Becton Dickinson (BD), David was responsible for integrating company-wide activities focused on the identification of new market opportunities outside of existing core areas, the development of high-impact growth concepts outside of, or across, existing business units and incubation of non-core offerings.
David is Chair of the Executive Council for The Center for Patient Safety Research and Practice, a thought leader in information-enabled healthcare safety. David serves as a board member and co-chair of the Digital Health Committee for the Life Science Angels, the #1 ranked angel investor group in the U.S. and for Health XL, a cross-industry consortia devoted to care transformation. With his work as a strategic advisor to several population health management companies as well as for Digital Health accelerators and incubators, David helps entrepreneurs and companies develop profitable businesses that profoundly improve healthcare quality and efficiency.
David received a Ph.D. in Mechanical Engineering from U.C. Berkeley for his work in virtual environments and medical simulation. He spent four years at medical simulator startups leading the development, commercialization and launch of state-of-the-art simulators. Prior to joining BD, David received an M.B.A. from the Harvard Business School.
Randall L. Schiestl, PMP, is the Vice President, R&D, Global Technology at Boston Scientific Corporation where he leads a team of talented R&D engineers, scientists and technicians chartered to develop and sustain a broad family of minimally invasive medical devices. Specific responsibilities include: technology management; product design; computational analysis, packaging, labeling and sterilization engineering; university relationships, new product development facilities and labs; knowledge management; and sustaining engineering. He has global responsibility for building technical community, emerging market sourcing and managing R&D information systems across BSC. His engineering teams are located across multiple facilities both US and OUS. Mr. Schiestl (Randy) has a BSME degree from the University of Minnesota, college of Science & Engineering, high distinction He also holds MBA and Executive MBA degrees from the University of Minnesota, Carlson School of Management. Randy has completed the Medical Technology Management mini-MBA at St Thomas University and is certified as a Project Management Professional. Work history includes Honeywell, Alliant Techsystems, and Boston Scientific with functional responsibilities in project and program management, product and process development, strategic planning, mergers and acquisitions, manufacturing management, supply chain, quality, information systems, test facilities, and operations. Randy serves on multiple local and national industry advisory boards and consortiums including the Medical Devices Industry Consortium, the Medical Industry Leadership Institute, Heart Advisory Committee Medical Alley, FIRST Robotics and UMN Biomedical, Medical Device Center, Nanotechnology IABs. He received the 2011 UMAA Alumni Service Award from the University of Minnesota, College of Science & Engineering and the Design of Medical Devices Conference Award in 2012.
Jeffrey E. Stahmann received his B.S. degree in electrical engineering in 1978 and M.S. degree in electrical engineering in 1985 from the University of Wisconsin-Madison and University of Minnesota-Twin Cities respectively.
Jeffrey is a Senior Fellow in Research and Development within Boston Scientific’s Rhythm Management Division and currently leads medical science and technology exploratory activities for the division. The role comprises identification and exploration of unmet medical needs and new technology applicable to electrically active medical devices.
He has almost 30 years of experience as a development engineer and research scientist on implantable medical devices and has held multiple leadership positions. His work has concentrated on electrically active implantable devices for cardiac therapy and diagnosis including pacemakers, defibrillators, cardiac resynchronizers, implantable ECG loop recorders and pressure sensors. Prior to his career in medical devices he designed custom integrated circuits for various aerospace applications and US government agencies.
Jeffrey has been issued over 300 US patents for electrical and mechanical design, materials, sensors and algorithms relating to medical devices.
Kate Taylor is a Global Innovation Manager at Boston Scientific, responsible for the coordination of various internal and external innovation programs across the company. Before this she was a Medical Device Innovation Fellow at the University of Minnesota in the area of digital health investigating the link between physiological markers and chronic pain with wearable sensors. She served as the VP of Engineering at Entarik leading the development of specialized feeding tubes for hospitalized patients. Kate also spent many years in Corporate R&D at Medtronic using her expertise in biomaterials, coatings and drug delivery working on a variety of medical devices including cardiac pacing, defibrillation and neuro stimulation leads, rechargeable neuro stimulators, mechanical heart valves, implantable and external drug pumps and catheters, glucose sensors and powered cutting tools.
Kate received her BS degree in Chemistry from the University of Virginia. She received her MS and PhD degrees in Materials Science and Engineering from the University of Cincinnati. Her ties with the UVA continue as a member of the Oversight Committee for the Biomedical Engineering Department's Coulter Translational Research Program.
Julie Thompson is an R&D Director at Boston Scientific Corporation where she leads a team of scientists and engineers focused on developing new diagnostic and therapy device features for improved cardiac patient management. Her responsibilities include providing strategic guidance, encouraging innovation, and overseeing concept development from the idea stage through feature design and clinical validation for new device capabilities across a range of BSC products. Julie has been with Boston Scientific for 18 years, holding scientist and management positions in cardiac research, with a focus over the last decade on novel heart failure diagnostics. Julie has a PhD degree in electrical engineering/signal processing from the University of Michigan.